Form 8-K - Current report:
SEC Accession No. 0001193125-25-063184
Filing Date
2025-03-26
Accepted
2025-03-26 07:38:33
Documents
15
Period of Report
2025-03-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d918658d8k.htm   iXBRL 8-K 27280
2 EX-99.1 d918658dex991.htm EX-99.1 38802
6 GRAPHIC g918658g0326082317981.jpg GRAPHIC 4212
  Complete submission text file 0001193125-25-063184.txt   205534

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20250326.xsd EX-101.SCH 2874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20250326_lab.xml EX-101.LAB 17926
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20250326_pre.xml EX-101.PRE 11254
18 EXTRACTED XBRL INSTANCE DOCUMENT d918658d8k_htm.xml XML 3653
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 25770193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)